TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$2.15M2014: $2.96M2015: $234.99M2016: $166.14M2017: $202.98M2018: $246.88M2019: $123.64M2020: $341.23M2021: $205.96M2022: $81.88M2023: $39.51M2024: $11.85M$11.85M
2013Shareholders' Equity (USD)2024
Fiscal YearShareholders' EquityChange YoY
2024$11.85M-70.0%
2023$39.51M-51.7%
2022$81.88M-60.2%
2021$205.96M-39.6%
2020$341.23M+176.0%
2019$123.64M-49.9%
2018$246.88M+21.6%
2017$202.98M+22.2%
2016$166.14M-29.3%
2015$234.99M+7847.0%
2014$2.96M+237.2%
2013-$2.15M—